![IEY IEY](https://data.pdbj.org/pdbjplus/data/cc/svg/IEY.svg) | IEY | Name: | {5-hydroxy-4-(4-hydroxybenzyl)-2-[(E)-2-(1H-imidazol-4-yl)ethenyl]-1H-imidazol-1-yl}acetic acid | Formula: | C17 H16 N4 O4 | SMILES: | O=C(O)Cn2c(O)c(nc2C=Cc1ncnc1)Cc3ccc(O)cc3 | InChi: | InChI=1S/C17H16N4O4/c22-13-4-1-11(2-5-13)7-14-17(25)21(9-16(23)24)15(20-14)6-3-12-8-18-10-19-12/h1-6,8,10,14,22H,7,9H2,(H,18,19)(H,23,24)/b6-3+/t14-/m0/s1 | Synonyms: | CHROMOPHORE (HIS-TYR-GLY) | Definition date: | 2005-06-01 | Last modified: | 2023-11-03 | Identifier: | {5-hydroxy-4-(4-hydroxybenzyl)-2-[(E)-2-(1H-imidazol-4-yl)ethenyl]-1H-imidazol-1-yl}acetic acid |
|
![IGL IGL](https://data.pdbj.org/pdbjplus/data/cc/svg/IGL.svg) | IGL | Name: | ALPHA-AMINO-2-INDANACETIC ACID | Formula: | C11 H13 N O2 | SMILES: | O=C(O)C(N)C2Cc1ccccc1C2 | InChi: | InChI=1S/C11H13NO2/c12-10(11(13)14)9-5-7-3-1-2-4-8(7)6-9/h1-4,9-10H,5-6,12H2,(H,13,14)/t10-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | (2R)-amino(2,3-dihydro-1H-inden-2-yl)ethanoic acid |
|
![IIC IIC](https://data.pdbj.org/pdbjplus/data/cc/svg/IIC.svg) | IIC | Name: | 4-IMIDAZOLMETHYLENE-5-IMIDAZOLONE CHROMOPHORE | Formula: | C11 H15 N5 O4 | SMILES: | O=C1C(=NC(N1CC(=O)O)C(N)CO)Cc2cncn2 | InChi: | InChI=1S/C11H15N5O4/c12-7(4-17)10-15-8(1-6-2-13-5-14-6)11(20)16(10)3-9(18)19/h2,5,7,10,17H,1,3-4,12H2,(H,13,14)(H,18,19)/t7-,10-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | [(2S)-2-[(1R)-1-amino-2-hydroxyethyl]-4-(1H-imidazol-5-ylmethyl)-5-oxo-2,5-dihydro-1H-imidazol-1-yl]acetic acid |
|
![L1F L1F](https://data.pdbj.org/pdbjplus/data/cc/svg/L1F.svg) | L1F | Name: | N-[2-(2-methoxyphenoxy)ethyl]-N-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide | Formula: | C20 H20 N2 O4 | SMILES: | COc1ccccc1OCCN(C)C(=O)C1=CC(=O)Nc2ccccc21 | InChi: | InChI=1S/C20H20N2O4/c1-22(11-12-26-18-10-6-5-9-17(18)25-2)20(24)15-13-19(23)21-16-8-4-3-7-14(15)16/h3-10,13H,11-12H2,1-2H3,(H,21,23) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-[2-(2-methoxyphenoxy)ethyl]-N-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide |
|
![L2I L2I](https://data.pdbj.org/pdbjplus/data/cc/svg/L2I.svg) | L2I | Name: | (2S)-4-(methylamino)-2-phenyl-N-(pyridin-3-yl)butanamide | Formula: | C16 H19 N3 O | SMILES: | O=C(Nc1cccnc1)C(CCNC)c1ccccc1 | InChi: | InChI=1S/C16H19N3O/c1-17-11-9-15(13-6-3-2-4-7-13)16(20)19-14-8-5-10-18-12-14/h2-8,10,12,15,17H,9,11H2,1H3,(H,19,20)/t15-/m0/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2S)-4-(methylamino)-2-phenyl-N-(pyridin-3-yl)butanamide |
|
![L3I L3I](https://data.pdbj.org/pdbjplus/data/cc/svg/L3I.svg) | L3I | Name: | 2-(3-chlorophenyl)-2-methyl-N-(4-methylpyridin-3-yl)propanamide | Formula: | C16 H17 Cl N2 O | SMILES: | O=C(Nc1cnccc1C)C(C)(C)c1cccc(Cl)c1 | InChi: | InChI=1S/C16H17ClN2O/c1-11-7-8-18-10-14(11)19-15(20)16(2,3)12-5-4-6-13(17)9-12/h4-10H,1-3H3,(H,19,20) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-2-methyl-N-(4-methylpyridin-3-yl)propanamide |
|
![L3R L3R](https://data.pdbj.org/pdbjplus/data/cc/svg/L3R.svg) | L3R | Name: | (2~{S},3~{R},4~{R},5~{S},6~{R})-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol | Formula: | C24 H25 F O5 S | SMILES: | Cc1ccc(cc1Cc2sc(cc2)c3ccc(F)cc3)[CH]4O[CH](CO)[CH](O)[CH](O)[CH]4O | InChi: | InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1 | Synonyms: | Canagliflozin | Definition date: | 2022-11-09 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2~{S},3~{R},4~{R},5~{S},6~{R})-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol |
|
![L4N L4N](https://data.pdbj.org/pdbjplus/data/cc/svg/L4N.svg) | L4N | Name: | (5R)-N-(4-methylpyridin-3-yl)spiro[2.4]heptane-5-carboxamide | Formula: | C14 H18 N2 O | SMILES: | O=C(Nc1cnccc1C)C1CCC2(CC2)C1 | InChi: | InChI=1S/C14H18N2O/c1-10-3-7-15-9-12(10)16-13(17)11-2-4-14(8-11)5-6-14/h3,7,9,11H,2,4-6,8H2,1H3,(H,16,17)/t11-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (5R)-N-(4-methylpyridin-3-yl)spiro[2.4]heptane-5-carboxamide |
|
![L4R L4R](https://data.pdbj.org/pdbjplus/data/cc/svg/L4R.svg) | L4R | Name: | Fmoc-(R)-2-(7-octenyl)alanine | Formula: | C11 H21 N O2 | SMILES: | C[C](N)(CCCCCCC=C)C(O)=O | InChi: | InChI=1S/C11H21NO2/c1-3-4-5-6-7-8-9-11(2,12)10(13)14/h3H,1,4-9,12H2,2H3,(H,13,14)/t11-/m1/s1 | Definition date: | 2022-06-16 | Last modified: | 2023-11-03 | Release date: | 2022-07-20 | Identifier: | (2~{R})-2-azanyl-2-methyl-dec-9-enoic acid |
|
![L4U L4U](https://data.pdbj.org/pdbjplus/data/cc/svg/L4U.svg) | L4U | Name: | (3S)-3,4-dimethyl-N-(4-methylpyridin-3-yl)pentanamide | Formula: | C13 H20 N2 O | SMILES: | O=C(Nc1cnccc1C)CC(C)C(C)C | InChi: | InChI=1S/C13H20N2O/c1-9(2)11(4)7-13(16)15-12-8-14-6-5-10(12)3/h5-6,8-9,11H,7H2,1-4H3,(H,15,16)/t11-/m0/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (3S)-3,4-dimethyl-N-(4-methylpyridin-3-yl)pentanamide |
|
![L5I L5I](https://data.pdbj.org/pdbjplus/data/cc/svg/L5I.svg) | L5I | Name: | (2R)-3-cyclopropyl-2-methyl-N-(4-methylpyridin-3-yl)propanamide | Formula: | C13 H18 N2 O | SMILES: | O=C(Nc1cnccc1C)C(C)CC1CC1 | InChi: | InChI=1S/C13H18N2O/c1-9-5-6-14-8-12(9)15-13(16)10(2)7-11-3-4-11/h5-6,8,10-11H,3-4,7H2,1-2H3,(H,15,16)/t10-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2R)-3-cyclopropyl-2-methyl-N-(4-methylpyridin-3-yl)propanamide |
|
![L6D L6D](https://data.pdbj.org/pdbjplus/data/cc/svg/L6D.svg) | L6D | Name: | N-(1H-benzimidazol-1-yl)-2-(3-chlorophenyl)acetamide | Formula: | C15 H12 Cl N3 O | SMILES: | Clc1cccc(c1)CC(=O)Nn1cnc2ccccc21 | InChi: | InChI=1S/C15H12ClN3O/c16-12-5-3-4-11(8-12)9-15(20)18-19-10-17-13-6-1-2-7-14(13)19/h1-8,10H,9H2,(H,18,20) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(1H-benzimidazol-1-yl)-2-(3-chlorophenyl)acetamide |
|
![L6R L6R](https://data.pdbj.org/pdbjplus/data/cc/svg/L6R.svg) | L6R | Name: | (2R)-2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)pentanamide | Formula: | C17 H19 Cl N2 O | SMILES: | O=C(Nc1cnccc1C)C(CCC)c1cccc(Cl)c1 | InChi: | InChI=1S/C17H19ClN2O/c1-3-5-15(13-6-4-7-14(18)10-13)17(21)20-16-11-19-9-8-12(16)2/h4,6-11,15H,3,5H2,1-2H3,(H,20,21)/t15-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2R)-2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)pentanamide |
|
![L7F L7F](https://data.pdbj.org/pdbjplus/data/cc/svg/L7F.svg) | L7F | Name: | 2-[(1S,5R)-bicyclo[3.1.0]hexan-1-yl]-N-(4-methylpyridin-3-yl)acetamide | Formula: | C14 H18 N2 O | SMILES: | O=C(Nc1cnccc1C)CC12CC2CCC1 | InChi: | InChI=1S/C14H18N2O/c1-10-4-6-15-9-12(10)16-13(17)8-14-5-2-3-11(14)7-14/h4,6,9,11H,2-3,5,7-8H2,1H3,(H,16,17)/t11-,14+/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-[(1S,5R)-bicyclo[3.1.0]hexan-1-yl]-N-(4-methylpyridin-3-yl)acetamide |
|
![L7Q L7Q](https://data.pdbj.org/pdbjplus/data/cc/svg/L7Q.svg) | L7Q | Name: | 3-methyl-N-(4-methylpyridin-3-yl)-3-phenylbutanamide | Formula: | C17 H20 N2 O | SMILES: | O=C(Nc1cnccc1C)CC(C)(C)c1ccccc1 | InChi: | InChI=1S/C17H20N2O/c1-13-9-10-18-12-15(13)19-16(20)11-17(2,3)14-7-5-4-6-8-14/h4-10,12H,11H2,1-3H3,(H,19,20) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 3-methyl-N-(4-methylpyridin-3-yl)-3-phenylbutanamide |
|
![L7V L7V](https://data.pdbj.org/pdbjplus/data/cc/svg/L7V.svg) | L7V | Name: | 1-[(2S)-2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl]-2-(pyridin-3-yl)ethan-1-one | Formula: | C16 H18 N4 O2 | SMILES: | O=C(Cc1cccnc1)N1CCCC1c1nc(on1)C1CC1 | InChi: | InChI=1S/C16H18N4O2/c21-14(9-11-3-1-7-17-10-11)20-8-2-4-13(20)15-18-16(22-19-15)12-5-6-12/h1,3,7,10,12-13H,2,4-6,8-9H2/t13-/m0/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-[(2S)-2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl]-2-(pyridin-3-yl)ethan-1-one |
|
![L83 L83](https://data.pdbj.org/pdbjplus/data/cc/svg/L83.svg) | L83 | Name: | N-(2-amino-4-methylpyridin-3-yl)-2-(3-chlorophenyl)acetamide | Formula: | C14 H14 Cl N3 O | SMILES: | Nc1nccc(C)c1NC(=O)Cc1cccc(Cl)c1 | InChi: | InChI=1S/C14H14ClN3O/c1-9-5-6-17-14(16)13(9)18-12(19)8-10-3-2-4-11(15)7-10/h2-7H,8H2,1H3,(H2,16,17)(H,18,19) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(2-amino-4-methylpyridin-3-yl)-2-(3-chlorophenyl)acetamide |
|
![L8F L8F](https://data.pdbj.org/pdbjplus/data/cc/svg/L8F.svg) | L8F | Name: | N-(2-{7-[(4-acetylpiperazin-1-yl)methyl]-1H-indol-3-yl}ethyl)acetamide | Formula: | C19 H26 N4 O2 | SMILES: | CC(=O)NCCc1c[NH]c2c(CN3CCN(CC3)C(C)=O)cccc21 | InChi: | InChI=1S/C19H26N4O2/c1-14(24)20-7-6-16-12-21-19-17(4-3-5-18(16)19)13-22-8-10-23(11-9-22)15(2)25/h3-5,12,21H,6-11,13H2,1-2H3,(H,20,24) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(2-{7-[(4-acetylpiperazin-1-yl)methyl]-1H-indol-3-yl}ethyl)acetamide |
|
![L8O L8O](https://data.pdbj.org/pdbjplus/data/cc/svg/L8O.svg) | L8O | Name: | 1-[(4R)-4-(3-methylphenyl)-3,4-dihydroisoquinolin-2(1H)-yl]ethan-1-one | Formula: | C18 H19 N O | SMILES: | Cc1cccc(c1)C1CN(Cc2ccccc21)C(C)=O | InChi: | InChI=1S/C18H19NO/c1-13-6-5-8-15(10-13)18-12-19(14(2)20)11-16-7-3-4-9-17(16)18/h3-10,18H,11-12H2,1-2H3/t18-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-[(4R)-4-(3-methylphenyl)-3,4-dihydroisoquinolin-2(1H)-yl]ethan-1-one |
|
![L93 L93](https://data.pdbj.org/pdbjplus/data/cc/svg/L93.svg) | L93 | Name: | 6-fluoro-N-[(2R)-2-(2-methoxyphenoxy)propyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide | Formula: | C20 H19 F N2 O4 | SMILES: | COc1ccccc1OC(C)CNC(=O)C1=CC(=O)Nc2ccc(F)cc21 | InChi: | InChI=1S/C20H19FN2O4/c1-12(27-18-6-4-3-5-17(18)26-2)11-22-20(25)15-10-19(24)23-16-8-7-13(21)9-14(15)16/h3-10,12H,11H2,1-2H3,(H,22,25)(H,23,24)/t12-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 6-fluoro-N-[(2R)-2-(2-methoxyphenoxy)propyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide |
|
![L9F L9F](https://data.pdbj.org/pdbjplus/data/cc/svg/L9F.svg) | L9F | Name: | (3P,5R)-3-(3-chlorophenyl)-5-(pyridin-3-yl)imidazolidine-2,4-dione | Formula: | C14 H10 Cl N3 O2 | SMILES: | Clc1cccc(c1)N1C(=O)C(NC1=O)c1cccnc1 | InChi: | InChI=1S/C14H10ClN3O2/c15-10-4-1-5-11(7-10)18-13(19)12(17-14(18)20)9-3-2-6-16-8-9/h1-8,12H,(H,17,20)/t12-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (3P,5R)-3-(3-chlorophenyl)-5-(pyridin-3-yl)imidazolidine-2,4-dione |
|
![L9O L9O](https://data.pdbj.org/pdbjplus/data/cc/svg/L9O.svg) | L9O | Name: | (1S)-N-(4-methylpyridin-3-yl)spiro[3.3]heptane-1-carboxamide | Formula: | C14 H18 N2 O | SMILES: | O=C(Nc1cnccc1C)C1CCC21CCC2 | InChi: | InChI=1S/C14H18N2O/c1-10-4-8-15-9-12(10)16-13(17)11-3-7-14(11)5-2-6-14/h4,8-9,11H,2-3,5-7H2,1H3,(H,16,17)/t11-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (1S)-N-(4-methylpyridin-3-yl)spiro[3.3]heptane-1-carboxamide |
|
![0WZ 0WZ](https://data.pdbj.org/pdbjplus/data/cc/svg/0WZ.svg) | 0WZ | Name: | 3-(1H-pyrazol-1-yl)-L-tyrosine | Formula: | C12 H13 N3 O3 | SMILES: | O=C(O)C(N)Cc1ccc(O)c(c1)n2nccc2 | InChi: | InChI=1S/C12H13N3O3/c13-9(12(17)18)6-8-2-3-11(16)10(7-8)15-5-1-4-14-15/h1-5,7,9,16H,6,13H2,(H,17,18)/t9-/m0/s1 | Definition date: | 2012-08-16 | Last modified: | 2023-11-03 | Release date: | 2012-08-24 | Identifier: | 3-(1H-pyrazol-1-yl)-L-tyrosine |
|
![LAV LAV](https://data.pdbj.org/pdbjplus/data/cc/svg/LAV.svg) | LAV | Name: | N-[(2S)-2-amino-4-methylpentyl]-L-valine | Formula: | C11 H24 N2 O2 | SMILES: | O=C(O)C(NCC(N)CC(C)C)C(C)C | InChi: | InChI=1S/C11H24N2O2/c1-7(2)5-9(12)6-13-10(8(3)4)11(14)15/h7-10,13H,5-6,12H2,1-4H3,(H,14,15)/t9-,10-/m0/s1 | Definition date: | 2010-10-28 | Last modified: | 2023-11-03 | Identifier: | N-[(2S)-2-amino-4-methylpentyl]-L-valine |
|
![LB0 LB0](https://data.pdbj.org/pdbjplus/data/cc/svg/LB0.svg) | LB0 | Name: | (1r,3r)-3-cyclopropyl-N-(4-methylpyridin-3-yl)cyclobutane-1-carboxamide | Formula: | C14 H18 N2 O | SMILES: | O=C(Nc1cnccc1C)C1CC(C1)C1CC1 | InChi: | InChI=1S/C14H18N2O/c1-9-4-5-15-8-13(9)16-14(17)12-6-11(7-12)10-2-3-10/h4-5,8,10-12H,2-3,6-7H2,1H3,(H,16,17)/t11-,12- | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (1r,3r)-3-cyclopropyl-N-(4-methylpyridin-3-yl)cyclobutane-1-carboxamide |
|